NASDAQ:PIII P3 Health Partners (PIII) Stock Price, News & Analysis $6.53 -0.30 (-4.35%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$6.45 -0.08 (-1.27%) As of 08/8/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About P3 Health Partners Stock (NASDAQ:PIII) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get P3 Health Partners alerts:Sign Up Key Stats Today's Range$6.37▼$6.7850-Day Range$5.80▼$7.4452-Week Range$5.80▼$31.50Volume5,849 shsAverage Volume12,615 shsMarket Capitalization$46.97 millionP/E RatioN/ADividend YieldN/APrice Target$16.25Consensus RatingModerate Buy Company Overview P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada. Read More P3 Health Partners Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks46th Percentile Overall ScorePIII MarketRank™: P3 Health Partners scored higher than 46% of companies evaluated by MarketBeat, and ranked 588th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingP3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageP3 Health Partners has received no research coverage in the past 90 days.Read more about P3 Health Partners' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for P3 Health Partners are expected to grow in the coming year, from ($0.67) to ($0.37) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of P3 Health Partners is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of P3 Health Partners is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioP3 Health Partners has a P/B Ratio of 0.62. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about P3 Health Partners' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.42% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in P3 Health Partners has recently decreased by 16.03%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldP3 Health Partners does not currently pay a dividend.Dividend GrowthP3 Health Partners does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.42% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in P3 Health Partners has recently decreased by 16.03%, indicating that investor sentiment is improving significantly. News and Social Media0.6 / 5News SentimentN/A Search Interest2 people have searched for PIII on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, P3 Health Partners insiders have not sold or bought any company stock.Percentage Held by Insiders17.79% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.75% of the stock of P3 Health Partners is held by institutions.Read more about P3 Health Partners' insider trading history. Receive PIII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address PIII Stock News HeadlinesP3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference CallJuly 31, 2025 | businesswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.July 28, 2025 | globenewswire.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.August 10 at 2:00 AM | Brownstone Research (Ad)Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.July 22, 2025 | globenewswire.comP3 Health Partners Inc. (PIII) - Yahoo FinanceJuly 2, 2025 | finance.yahoo.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.June 16, 2025 | globenewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.June 6, 2025 | globenewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.June 3, 2025 | globenewswire.comSee More Headlines PIII Stock Analysis - Frequently Asked Questions How have PIII shares performed this year? P3 Health Partners' stock was trading at $11.2450 at the beginning of 2025. Since then, PIII stock has decreased by 41.9% and is now trading at $6.5330. How were P3 Health Partners' earnings last quarter? P3 Health Partners Inc. (NASDAQ:PIII) issued its quarterly earnings data on Thursday, May, 15th. The company reported ($6.28) earnings per share for the quarter, missing analysts' consensus estimates of ($5.00) by $1.28. The business earned $373.23 million during the quarter, compared to analysts' expectations of $362.09 million. P3 Health Partners had a negative net margin of 9.27% and a negative trailing twelve-month return on equity of 123.10%. Read the conference call transcript. When did P3 Health Partners' stock split? Shares of P3 Health Partners reverse split on the morning of Monday, April 14th 2025.The 1-50 reverse split was announced on Friday, April 4th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 11th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. Who are P3 Health Partners' major shareholders? Top institutional shareholders of P3 Health Partners include Trinity Financial Advisors LLC (0.35%) and Geode Capital Management LLC (0.28%). Insiders that own company stock include Pacific Founders Ugp Chicago, Pacific Founders Ugp I Chicago, Sherif Abdou and Atul Kavthekar. View institutional ownership trends. How do I buy shares of P3 Health Partners? Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of P3 Health Partners own? Based on aggregate information from My MarketBeat watchlists, some other companies that P3 Health Partners investors own include Avino Silver & Gold Mines (ASM), PayPal (PYPL), TriNet Group (TNET), Taiwan Semiconductor Manufacturing (TSM), XPeng (XPEV), 3M (MMM) and nCino (NCNO). Company Calendar Last Earnings5/15/2025Today8/10/2025Next Earnings (Confirmed)8/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryHealthcare Current SymbolNASDAQ:PIII CIK1832511 Webforesightacq.com Phone702-910-3950FaxN/AEmployees500Year FoundedN/APrice Target and Rating Average Price Target for P3 Health Partners$16.25 High Price Target$20.00 Low Price Target$12.50 Potential Upside/Downside+148.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($47.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$135.85 million Net Margins-9.27% Pretax Margin-20.31% Return on Equity-123.10% Return on Assets-15.94% Debt Debt-to-Equity Ratio1.68 Current Ratio0.38 Quick Ratio0.38 Sales & Book Value Annual Sales$1.50 billion Price / Sales0.03 Cash FlowN/A Price / Cash FlowN/A Book Value$10.58 per share Price / Book0.62Miscellaneous Outstanding Shares7,190,000Free Float5,909,000Market Cap$46.97 million OptionableNot Optionable Beta0.81 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:PIII) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.